CRIS Curis Inc

-0.0081 (-1.91%)
Last Updated: 14:29:51
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 245,801
Bid Price 0.415
Ask Price 0.43
News -
Day High 0.448699


52 Week Range


Day Low 0.41
Company Name Stock Ticker Symbol Market Type
Curis Inc CRIS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0081 -1.91% 0.415 14:29:51
Open Price Low Price High Price Close Price Prev Close
0.4193 0.41 0.448699 0.4231
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
496 245,801 $ 0.4379358 $ 107,645 - 0.41 - 1.00
Last Trade Time Type Quantity Stock Price Currency
14:32:36 10 $ 0.43 USD

Curis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
48.85M 117.70M - 10.16M -56.67M -0.48 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Curis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CRIS Message Board. Create One! See More Posts on CRIS Message Board See More Message Board Posts

Historical CRIS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.45490.46380.410.4376676205,843-0.0399-8.77%
1 Month0.5890.590.410.4982578271,103-0.174-29.54%
3 Months0.810.900.410.666237326,077-0.395-48.77%
6 Months0.531.000.410.7472352331,232-0.115-21.7%
1 Year0.70951.000.410.705003503,994-0.2945-41.51%
3 Years1.0917.400.415.612,322,755-0.675-61.93%
5 Years1.6217.400.414.891,693,216-1.21-74.38%

Curis Description

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.